Pfizer's Kristofco comments on outcomes-oriented CME

During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma “continues to have an expectation for more outcomes-oriented CME,” and that he expects grants from public and private sources will “begin to assess the current climate for [CPD].”

You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.